Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of two amino acids, l-ornithine and l-aspartate. It is believed to reduce ammonia levels in the blood by stimulating the urea cycle and glutamine synthesis in the liver.
## Primary Indications
Treatment of hyperammonemia associated with liver disease, such as cirrhosis, particularly in patients with hepatic encephalopathy.
## Adult Dosing
Intravenous (IV) administration is common.
* **Initial Dose:** 5 grams IV every 8 hours.
* **Maintenance Dose:** 5-10 grams IV every 8-12 hours, depending on patient response and ammonia levels.
* **Maximum Dose:** Typically not to exceed 20 grams daily. Specific maximum doses may vary based on local protocols and clinical judgment.
Oral formulations may also be available, with typical doses ranging from 3-6 grams taken 2-3 times daily.
## Pediatric Dosing
* **Established pediatric dosing is not widely available or consistently defined.** Dosing in children requires careful consideration and is often based on institutional protocols or extrapolated from adult data, with close monitoring.
## Dose Adjustments
* **Renal Impairment:** Use with caution. While the drug is primarily metabolized by the liver, monitor renal function and adjust dose if necessary, though specific guidelines are limited.
* **Hepatic Impairment:** The drug is intended for patients with hepatic impairment; however, the degree of impairment may influence the required dose and frequency.
## Contraindications
* Known hypersensitivity to l-ornithine or l-aspartate.
* Severe renal failure.
## Adverse Effects
* Gastrointestinal: Nausea, vomiting, diarrhea, abdominal discomfort.
* Neurological: Dizziness, headache.
* Rarely, rash or allergic reactions.
## Key Drug Interactions
* **Barbiturates:** Potential for potentiation of sedative effects.
* **Other CNS Depressants:** Caution and potential dose adjustments may be warranted.
## Monitoring
* Plasma ammonia levels.
* Liver function tests (LFTs).
* Renal function tests (BUN, creatinine).
* Clinical signs and symptoms of hepatic encephalopathy.
## Clinical Pearls
* This medication is often used as an adjunct to other therapies for liver disease and hepatic encephalopathy.
* IV administration may be preferred for more rapid correction of hyperammonemia.
* Response to therapy can be variable.
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information, drug compendia, or institutional protocols for complete and up-to-date guidance before making any treatment decisions.
